Gilead Sciences On Track for Largest Percent Increase Since August 2023 — Data Talk
Gilead Sciences, Inc. (GILD) is currently at $65.45, up $2.30 or 3.64%
--Would be highest close since May 24, 2024, when it closed at $65.68
--On pace for largest percent increase since Aug. 4, 2023, when it rose 4.17%
--Snaps a two day losing streak
--Up 1.84% month-to-date
--Down 19.21% year-to-date
--Down 46.44% from its all-time closing high of $122.21 on June 23, 2015
--Down 16.21% from 52 weeks ago (June 22, 2023), when it closed at $78.11
--Down 25.02% from its 52-week closing high of $87.29 on Jan. 19, 2024
--Up 3.64% from its 52-week closing low of $63.15 on June 18, 2024
--Traded as high as $66.78; highest intraday level since May 23, 2024, when it hit $67.63
--Up 5.75% at today's intraday high; largest intraday percent increase since Aug. 4, 2023, when it rose as much as 6.1%
--Sixth best performer in the S&P 500 today
--Second best performer in the Nasdaq 100 today
All data as of 10:07:51 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 20, 2024 10:24 ET (14:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks